The FDA Wants this Highly Addictive Opioid Taken off the Market

On June 8, 2017, the FDA requested that the drug-maker Endo Pharmaceuticals stop selling Opana ER – the extended-release version of Opana – because of “public health consequences of abuse.” It is the first time the agency has made efforts to pull an opioid from the market due to its highly addictive nature. [1] According […]

Study: Cannabidiol-Based Medication Reduces Intense Seizures by 50% (4-20-2017)

Marijuana has been associated with reducing seizures in people with epilepsy for years, but only now is the topic getting more of the scientific scrutiny it deserves. In a recent study, cannabidiol (CBD) reduced the number of seizures by half in a substantial number of children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy. GW […]

FDA: Invokana Diabetes Drug Increases Risk of Foot and Leg Amputations

The U.S. Food and Drug Administration (FDA) confirms the popular Johnson & Johnson (J&J) diabetes drug Invokana (Invokamet, Invokamet XR) increases the risk of foot and leg amputations in people with Type 2 diabetes. [1] The results of 2 clinical trials showed leg and foot amputations occurred about twice as often in patients taking Invokana […]

The United Nations Says It Will Monitor the Fentanyl Market

On March 16, the United Nations (U.N.) added 2 chemicals used to make the painkiller fentanyl to an international list of controlled substances. Assistant Secretary of State William Brownfield, the chief U.S. State Department counter-narcotics official, has hailed the move, but acknowledged that it won’t immediately decrease illegal trafficking of the chemicals. [1] [2] Source: Healthland Heart […]